Ameriprise’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.4M | Buy |
143,451
+52,174
| +57% | +$3.65M | ﹤0.01% | 2157 |
|
|
2025
Q4 | $8.42M | Buy |
91,277
+2,206
| +2% | +$211K | ﹤0.01% | 2045 |
|
|
2025
Q3 | $6.61M | Sell |
89,071
-23,379
| -21% | -$2.37M | ﹤0.01% | 2215 |
|
|
2025
Q2 | $14.6M | Sell |
112,450
-9,610
| -8% | -$1.39M | ﹤0.01% | 1542 |
|
|
2025
Q1 | $19.4M | Buy |
122,060
+17,304
| +17% | +$3.13M | 0.01% | 1334 |
|
|
2024
Q4 | $19.4M | Sell |
104,756
-77,409
| -42% | -$15M | 0.01% | 1353 |
|
|
2024
Q3 | $38.4M | Sell |
182,165
-49,863
| -21% | -$8.66M | 0.01% | 970 |
|
|
2024
Q2 | $31.1M | Sell |
232,028
-199,415
| -46% | -$37.7M | 0.01% | 1028 |
|
|
2024
Q1 | $92.7M | Sell |
431,443
-59,827
| -12% | -$11.7M | 0.03% | 562 |
|
|
2023
Q4 | $99.9M | Buy |
491,270
+157,779
| +47% | +$25.6M | 0.03% | 521 |
|
|
2023
Q3 | $66.2M | Sell |
333,491
-797
| -0.2% | -$201K | 0.02% | 639 |
|
|
2023
Q2 | $109M | Buy |
334,288
+6,823
| +2% | +$1.95M | 0.03% | 483 |
|
|
2023
Q1 | $76.6M | Sell |
327,465
-9,984
| -3% | -$2.52M | 0.03% | 586 |
|
|
2022
Q4 | $85M | Buy |
337,449
+68,711
| +26% | +$14.7M | 0.03% | 523 |
|
|
2022
Q3 | $47.7M | Sell |
268,738
-75,504
| -22% | -$15.2M | 0.02% | 726 |
|
|
2022
Q2 | $62.9M | Sell |
344,242
-112,074
| -25% | -$22.3M | 0.02% | 639 |
|
|
2022
Q1 | $117M | Buy |
456,316
+296,112
| +185% | +$67.7M | 0.03% | 472 |
|
|
2021
Q4 | $36.9M | Buy |
160,204
+28,966
| +22% | +$7.07M | 0.01% | 983 |
|
|
2021
Q3 | $30.6M | Buy |
131,238
+68,825
| +110% | +$14.4M | 0.01% | 995 |
|
|
2021
Q2 | $12.1M | Buy |
62,413
+31,235
| +100% | +$6.19M | ﹤0.01% | 1783 |
|
|
2021
Q1 | $6.45M | Buy |
31,178
+3,545
| +13% | +$753K | ﹤0.01% | 2227 |
|
|
2020
Q4 | $5.2M | Buy |
27,633
+3,324
| +14% | +$543K | ﹤0.01% | 2244 |
|
|
2020
Q3 | $3.14M | Buy |
24,309
+610
| +3% | +$67.2K | ﹤0.01% | 2396 |
|
|
2020
Q2 | $2.06M | Sell |
23,699
-6,306
| -21% | -$485K | ﹤0.01% | 2590 |
|
|
2020
Q1 | $1.81M | Sell |
30,005
-873
| -3% | -$64.6K | ﹤0.01% | 2533 |
|
|
2019
Q4 | $2.29M | Sell |
30,878
-18,076
| -37% | -$1.16M | ﹤0.01% | 2666 |
|
|
2019
Q3 | $2.99M | Buy |
48,954
+12,832
| +36% | +$845K | ﹤0.01% | 2486 |
|
|
2019
Q2 | $2.19M | Buy |
+36,122
| New | +$1.95M | ﹤0.01% | 2693 |
|
|
2019
Q1 | – | Sell |
-30,279
| Closed | -$1.28M | – | 3730 |
|
|
2018
Q4 | $1.28M | Hold |
30,279
| – | – | ﹤0.01% | 2843 |
|
|
2018
Q3 | $1.27M | Sell |
30,279
-5,197
| -15% | -$244K | ﹤0.01% | 2982 |
|
|
2018
Q2 | $1.26M | Buy |
+35,476
| New | +$1.15M | ﹤0.01% | 2930 |
|
Other funds holding INSP
DM
VPM
VCM
Ameriprise's INSP Position: Q1 2026 in Review
Ameriprise increased its Inspire Medical Systems (INSP) stake by 57% in Q1 2026, buying an estimated $3.65M and bringing the position to 143,451 shares worth $7.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2157.
Ameriprise first reported a position in INSP in Q2 2018 and has held it in 31 quarters since. The position peaked at $117M in Q1 2022. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- Ameriprise held 143,451 shares of Inspire Medical Systems worth $7.4M as of Q1 2026.
- Ameriprise bought 52,174 Inspire Medical Systems shares in Q1 2026, an estimated $3.65M.
- Inspire Medical Systems made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2157 holding.
- Ameriprise first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 31 quarters since.
- Ameriprise's Inspire Medical Systems position peaked at $117M in Q1 2022.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.